By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Imprimis Pharmaceuticals 

12264 El Camino Real
Suite 350
San Diego  California  92130-0001  U.S.A.
Phone: 858-704-4040 Fax: 858-345-1745


SEARCH JOBS


Key Statistics


Email:
Ownership: Public

Web Site: Imprimis
Employees:
Symbol: immy
 









Company News
Imprimis (immy) Announces Plans To Launch IV Free Conscious Sedation And New Compounded Triple Drop Formulations At Leading Cataract And Refractive Surgeons Meeting 5/5/2016 8:00:31 AM
Imprimis (immy) To Host Its First Quarter 2016 Financial Report Conference Call And Webcast On May 12, 2016 At 4:30 P.M. EDT 5/4/2016 7:31:31 AM
Imprimis (immy) Begins Dispensing Lower Cost Alternative To Thiola 5/2/2016 9:18:07 AM
Imprimis (immy) Registers Its Texas Facility With The FDA As An Outsourcing Facility 4/12/2016 6:18:45 AM
Imprimis (immy) Announces Fourth Quarter And Year-End 2015 Financial Results And Provides Business Update 3/24/2016 6:49:14 AM
Imprimis (immy) To Host Its Fourth Quarter And Fiscal Year 2015 Financial Report Conference Call And Webcast On March 23, 2016 At 4:30 P.M. EDT 3/17/2016 8:38:57 AM
Imprimis (immy) Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares 3/17/2016 6:18:45 AM
Imprimis (immy) Announces Pricing Of Public Offering Of Common Stock 3/11/2016 7:24:20 AM
Imprimis (immy) Announces Proposed Public Offering Of Common Stock 3/11/2016 6:30:52 AM
Imprimis (immy) To Present At 28th Annual ROTH Conference On March 16, 2016 3/4/2016 10:02:56 AM
123456789
//-->